Skip to main content

Hye-Won Jeong

Korea Advanced Institute of Science and Technology · 情報科学

研究室紹介

Professor Hye-Won Jeong's research lab focuses on the molecular mechanisms underlying gastrointestinal carcinogenesis, with a particular emphasis on pancreatic and gastric cancers. The lab investigates key biomarkers such as HMGB1, Oct4, and Nanog in early carcinogenesis, tumor microenvironment modulation, and angiogenesis. Their work integrates clinical biomarker discovery with translational research, aiming to improve early diagnosis, prognosis prediction, and therapeutic strategies for pancreatic ductal adenocarcinoma and gastric cancer.

pancreatic cancergastric cancerHMGB1biomarkerscarcinogenesis

Research Overview

Papers
149
Total Citations
1,884
Papers (5y)
55
Primary Field
情報科学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
55total
2022
2023
2024
2025
2026
Citations per year (5y)
214total
20222023202420252026

Selected Papers

15
1
Article|176 citations·2006
The Clinical Usefulness of 18-Fluorodeoxyglucose Positron Emission Tomography in the Differential Diagnosis, Staging, and Response Evaluation After Concurrent Chemoradiotherapy for Pancreatic Cancer
Seungmin Bang, Hye Won Chung, Seung Woo Park, Jae Bock Chung, Mijin Yun, Jong Doo Lee, Si Young Song
SJR Q2Journal of Clinical GastroenterologyOA

FDG-PET is a very useful tool in diagnosing pancreatic cancer. FDG-PET may be also used as an adjunct for determining the treatment modality of pancreatic cancer and evaluating tumor response to chemoradiation therapy.

OncologyMedicine
2
Article|137 citations·2010
Oct4 and Nanog Expression Is Associated With Early Stages of Pancreatic Carcinogenesis
Jing Wen, Jeong Youp Park, Kyung Hwa Park, Hye Won Chung, Seungmin Bang, Seung Woo Park, Si Young Song
SJR Q2PancreasOA

The strong expression of Oct4 and Nanog in metaplastic ducts and Oct4 expression preceding Ras mutation suggests that these homeobox transcription factors are associated with the early stage of pancreatic cancer carcinogenesis and may play an important role in that process.

Molecular BiologyBiochemistry, Genetics and Molecular Biology
3
Article|122 citations·2009
Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer
Hye Won Chung, Sang‐Guk Lee, Heejung Kim, Duck Jin Hong, Jae Bock Chung, David Stroncek, Jong‐Baeck Lim
SJR Q1Journal of Translational MedicineOA

BACKGROUND: High mobility group box-1 (HMGB1) is a newly recognized factor regulating cancer cell tumorigenesis, expansion and invasion. We investigated the correlation between the serum HMGB1 levels and the clinical and pathologic features of gastric cancer and evaluated the validity of HMGB1 as a potential biomarker for the early diagnosis of gastric cancer. METHODS: A total of 227 subjects were classified into 5 disease groups according to the 'gastritis-dysplasia-carcinoma' sequence of gastr

Clinical BiochemistryBiochemistry, Genetics and Molecular Biology
4
Review|106 citations·2014
Role of the tumor microenvironment in the pathogenesis of gastric carcinoma
Hye Won Chung
SJR Q1World Journal of GastroenterologyOA

Gastric carcinoma (GC) is the 4(th) most prevalent cancer and has the 2(nd) highest cancer-related mortality rate worldwide. Despite the incidence of GC has decreased over the past few decades, it is still a serious health problem. Chronic inflammatory status of the stomach, caused by the infection of Helicobacter pylori (H. pylori) and through the production of inflammatory mediators within the parenchyma is suspected to play an important role in the initiation and progression of GC. In this re

SurgeryMedicine
5
Article|48 citations·2012
Serum high mobility group box‐1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma
Hye Won Chung, Jong‐Baeck Lim, Sunphil Jang, Kyong Joo Lee, Kyung Hwa Park, Si Young Song
SJR Q1Cancer ScienceOA

Extracellular high mobility group box-1 (HMGB1) contributes to tumor growth and invasiveness. We evaluated the diagnostic and prognostic ability of serum HMGB1 for pancreatic ductal adenocarcinoma (PDAC). Serum HMGB1 measured by enzyme-linked immunosorbent assay (ELISA) were compared among normal, chronic pancreatitis, PDAC group in both training (n = 25, each group) and independent validation set (n = 45, each group). To determine the usability of serum HMGB1 as a diagnostic predictor of PDAC,

Clinical BiochemistryBiochemistry, Genetics and Molecular Biology
6
Article|47 citations·2004
A prospective randomized study of gemcitabine with doxifluridine versus paclitaxel with doxifluridine in concurrent chemoradiotherapy for locally advanced pancreatic cancer
Hye Won Chung, Seungmin Bang, Seung Woo Park, Jae Bock Chung, Jin Kyung Kang, Ju Won Kim, Jin Sil Seong, Woo Jung Lee, Si Young Song
SJR Q1International Journal of Radiation Oncology*Biology*PhysicsOA
OncologyMedicine
7
Article|46 citations·2017
High‐mobility group box‐1 contributes tumor angiogenesis under interleukin‐8 mediation during gastric cancer progression
Hye Won Chung, Jong‐Baeck Lim
SJR Q1Cancer ScienceOA

Many soluble factors are involved in tumor angiogenesis. Thus, it is valuable to identify novel soluble factors for effective control of tumor angiogenesis in gastric cancer (GC). We investigated the role of extracellular high-mobility group box-1 (HMGB1) and its associated soluble factors in the tumor angiogenesis of GC. Clinically, we measured serum levels of HMGB1 and GC-associated cytokines/chemokines using GC serum samples (n = 120), and calculated microvessel density (MVD) by CD34 immunost

Molecular BiologyBiochemistry, Genetics and Molecular Biology
8
Article|39 citations·2015
Combined targeting of high‐mobility group box‐1 and interleukin‐8 to control micrometastasis potential in gastric cancer
Hye Won Chung, Sunphil Jang, Hoguen Kim, Jong‐Baeck Lim
SJR Q1International Journal of CancerOA

Micrometastasis is the major cause of treatment failure in gastric cancer (GC). Because epithelial-to-mesenchymal transition (EMT) is considered to develop prior to macroscopic metastasis, EMT-promoting factors may affect micrometastasis. This study aimed to evaluate the role of extracellular high-mobility group box-1 (HMGB1) in EMT and the treatment effect of combined targeting of HMGB1 and interleukin-8 (IL-8) at early-stage GC progression through interrupting EMT promotion. Extracellular HMGB

Clinical BiochemistryBiochemistry, Genetics and Molecular Biology
9
Article|37 citations·2015
Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer
Jong‐Baeck Lim, Hye Won Chung
SJR Q1CytokineOA
Pulmonary and Respiratory MedicineMedicine
10
Article|32 citations·2019
Combined treatment with 2′-hydroxycinnamaldehyde and temozolomide suppresses glioblastoma tumorspheres by decreasing stemness and invasiveness
Hyewon Jeong, Junseong Park, Jin‐Kyoung Shim, Jae Eun Lee, Nam Hee Kim, Hyun Sil Kim, Jong Hee Chang, Jong In Yook, Seok‐Gu Kang
SJR Q1Journal of Neuro-OncologyOA
GeneticsMedicine
11
Article|29 citations·2008
Comparison of the Validity of Three Biomarkers for Gastric Cancer Screening
Hye Won Chung, Ju Won Kim, Jong-han Lee, Si Young Song, Jae Bock Chung, Oh Hun Kwon, Jong‐Baeck Lim
SJR Q2Journal of Clinical GastroenterologyOA

The combination of serum hsCRP and PG I/II ratio would be helpful as a screening tool for gastric cancer in high incidence populations and may help to select high-risk subjects in need of further specific invasive screening tools such as endoscopy.

SurgeryMedicine
12
Article|27 citations·2004
Comparison of hydrocolonic sonograpy accuracy in preoperative staging between colon and rectal cancer
Hye Won Chung, Jae Bock Chung, Seung Woo Park, Si Young Song, Jin Kyung Kang, Chan Il Park
SJR Q1World Journal of GastroenterologyOA

HUS is valuable to evaluate the depth of invasion in colon cancer, but is less valuable in rectal cancer. Because HUS is low-cost, noninvasive, and readily available at any place, this technique seems to be useful to determine the preoperative staging in colon cancer, but not in rectal cancer.

OncologyMedicine
13
Article|22 citations·2009
Radiosensitization Effect of STI-571 on Pancreatic Cancer Cells In Vitro
Hye Won Chung, Jing Wen, Jong‐Baeck Lim, Seungmin Bang, Seung Woo Park, Si Young Song
SJR Q1International Journal of Radiation Oncology*Biology*PhysicsOA
OncologyMedicine
14
Article|16 citations·2011
Clinical significance of serum levels of immune‐associated molecules, uric acid and soluble MHC class I chain‐related molecules A and B, as diagnostic tumor markers for pancreatic ductal adenocarcinoma
Hye Won Chung, Jong‐Baeck Lim
SJR Q1Cancer ScienceOA

Immune-associated molecules play important roles in cancer development and progression. The aims of this study were to determine the diagnostic utility of uric acid (UA) and soluble MHC class I chain-related molecules A (sMICA) and B (sMICB) in pancreatic ductal adenocarcinoma (PDAC) compared with those of cancer antigen 19-9 (CA19-9), the most commonly available tumor marker for PDAC. We evaluated serum levels of UA, sMICA and sMICB along the carcinogenic process of PDAC obtained from 148 indiv

ImmunologyImmunology and Microbiology
15
Article|15 citations·2011
On capacity of optical channels with coherent detection
Hye Won Chung, Saikat Guha, Lizhong Zheng

Optical channel with direct detections, also known as Poisson channel, is well studied. With direction detections, only the intensity of the optical signal is measured and used as the carrier of information. In coherent detection, the phase of optical signal is also utilized. Constrained by optical devices, it is hard to directly measure this phase. However, it is possible to mix the input signal with a local reference signal to create output that is phase dependent. Generating such local signal

Artificial IntelligenceComputer Science

Research Areas

Artificial IntelligenceMolecular BiologyOncologyElectrical and Electronic EngineeringComputer Science ApplicationsImmunology

Hye-Won Jeongの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。